VEGFC and neoplasm: Dorsal MLV ablation reduced the efficacy of anti-PD-1/ CTLA-4 combination therapy for GL261 tumors, while mice with tumors overexpressing VEGF-C consistently showed decreased tumor sizes and tumor weight, highlighting the critical role MLVs play in anti-tumor therapy [76].